Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh
- PMID: 29684006
- PMCID: PMC5912711
- DOI: 10.1371/journal.pntd.0006399
Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh
Erratum in
-
Correction: Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.PLoS Negl Trop Dis. 2021 Jul 19;15(7):e0009616. doi: 10.1371/journal.pntd.0009616. eCollection 2021 Jul. PLoS Negl Trop Dis. 2021. PMID: 34280200 Free PMC article.
Abstract
Background: The mediators of protection against cholera, a severe dehydrating illness of humans caused by Vibrio cholerae, are unknown. We have previously shown that plasma IgA as well as memory B IgG cells targeting lipopolysaccharide (LPS) of Vibrio cholerae O1 correlate with protection against V. cholerae O1 infection among household contacts of cholera patients. Protection against cholera is serogroup specific, and serogroup specificity is defined by the O-specific polysaccharide (OSP) component of LPS. Therefore, we prospectively followed household contacts of cholera patients to determine whether OSP-specific immune responses present at the time of enrollment are associated with protection against V. cholerae infection.
Methodology: In this study, we enrolled two hundred forty two household contacts of one hundred fifty index patients who were infected with Vibrio cholerae. We determined OSP-specific memory B cells and plasma IgA, IgG and IgM antibody responses on study entry (day 2).
Principle findings: The presence of OSP-specific plasma IgA, IgM, and IgG antibody responses on study entry were associated with a decrease in the risk of infection in household contacts (IgA, p = 0.015; IgM, p = 0.01, and IgG, p = 0.024). In addition, the presence of OSP-specific IgG memory B cell responses in peripheral blood on study entry was also associated with a decreased risk of infection (44% reduction; 95% CI: 31.1 to 99.8) in contacts. No protection was associated with cholera toxin B subunit (CtxB)-specific memory B cell responses.
Conclusion: These results suggest that immune responses that target OSP, both in plasma and memory responses, may be important in mediating protection against infection with V. cholerae O1.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures





Similar articles
-
O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh.Clin Vaccine Immunol. 2016 May 6;23(5):427-435. doi: 10.1128/CVI.00647-15. Print 2016 May. Clin Vaccine Immunol. 2016. PMID: 27009211 Free PMC article.
-
Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.PLoS Negl Trop Dis. 2019 Aug 1;13(8):e0007634. doi: 10.1371/journal.pntd.0007634. eCollection 2019 Aug. PLoS Negl Trop Dis. 2019. PMID: 31369553 Free PMC article.
-
Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh.Clin Vaccine Immunol. 2012 Jun;19(6):842-8. doi: 10.1128/CVI.00037-12. Epub 2012 Apr 18. Clin Vaccine Immunol. 2012. PMID: 22518009 Free PMC article.
-
Immune responses to cholera in children.Expert Rev Anti Infect Ther. 2012 Apr;10(4):435-44. doi: 10.1586/eri.12.23. Expert Rev Anti Infect Ther. 2012. PMID: 22512753 Free PMC article. Review.
-
Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review.PLoS Negl Trop Dis. 2021 May 20;15(5):e0009383. doi: 10.1371/journal.pntd.0009383. eCollection 2021 May. PLoS Negl Trop Dis. 2021. PMID: 34014927 Free PMC article. Review.
Cited by
-
Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model.Clin Exp Vaccine Res. 2018 Jul;7(2):104-110. doi: 10.7774/cevr.2018.7.2.104. Epub 2018 Jul 31. Clin Exp Vaccine Res. 2018. PMID: 30112349 Free PMC article.
-
Bacteria That Cause Enteric Diseases Stimulate Distinct Humoral Immune Responses.Front Immunol. 2020 Sep 16;11:565648. doi: 10.3389/fimmu.2020.565648. eCollection 2020. Front Immunol. 2020. PMID: 33042146 Free PMC article. Review.
-
Inactivated Vibrio cholerae Strains That Express TcpA via the toxT-139F Allele Induce Antibody Responses against TcpA.J Microbiol Biotechnol. 2022 Nov 28;32(11):1396-1405. doi: 10.4014/jmb.2209.09001. Epub 2022 Oct 12. J Microbiol Biotechnol. 2022. PMID: 36317425 Free PMC article.
-
Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of Vibrio cholerae O1 Vaccination.Pathog Immun. 2022 Aug 24;7(1):122-144. doi: 10.20411/pai.v7i1.525. eCollection 2022. Pathog Immun. 2022. PMID: 36072570 Free PMC article.
-
Vibriocidal Titer and Protection From Cholera in Children.Open Forum Infect Dis. 2019 Feb 11;6(4):ofz057. doi: 10.1093/ofid/ofz057. eCollection 2019 Apr. Open Forum Infect Dis. 2019. PMID: 30997364 Free PMC article.
References
-
- Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB (2012) Cholera. Lancet 379: 2466–2476. doi: 10.1016/S0140-6736(12)60436-X - DOI - PMC - PubMed
-
- Johnson RA, Uddin T, Aktar A, Mohasin M, Alam MM, et al. (2012) Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera. Clin Vaccine Immunol 19: 1712–1721. doi: 10.1128/CVI.00321-12 - DOI - PMC - PubMed
-
- Uddin T, Aktar A, Xu P, Johnson RA, Rahman MA, et al. (2014) Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera. Am J Trop Med Hyg 90: 873–881. doi: 10.4269/ajtmh.13-0498 - DOI - PMC - PubMed
-
- Aktar A, Rahman MA, Afrin S, Faruk MO, Uddin T, et al. (2016) O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh. Clin Vaccine Immunol 23: 427–435. doi: 10.1128/CVI.00647-15 - DOI - PMC - PubMed
-
- Leung DT, Uddin T, Xu P, Aktar A, Johnson RA, et al. (2013) Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vaccine Immunol 20: 780–788. doi: 10.1128/CVI.00035-13 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 DK043351/DK/NIDDK NIH HHS/United States
- R03 AI063079 /NH/NIH HHS/United States
- U01 AI058935 /NH/NIH HHS/United States
- K43 TW010362 /NH/NIH HHS/United States
- R01 AI099243/AI/NIAID NIH HHS/United States
- K08 AI089721 /NH/NIH HHS/United States
- R01 AI106878/AI/NIAID NIH HHS/United States
- R01 AI106878 /NH/NIH HHS/United States
- AI103055 /NH/NIH HHS/United States
- K08 AI089721/AI/NIAID NIH HHS/United States
- U01 AI058935/AI/NIAID NIH HHS/United States
- D43 TW005572/TW/FIC NIH HHS/United States
- R03 AI063079/AI/NIAID NIH HHS/United States
- AI099243 /NH/NIH HHS/United States
- D43 TW005572 /NH/NIH HHS/United States
- R01 AI103055/AI/NIAID NIH HHS/United States
- R37 AI106878/AI/NIAID NIH HHS/United States
- K43 TW010362/TW/FIC NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous